Division of Clinical Research

Office of the Vice President and Innovation

Still submitting paper to CDER? Send electronically with CDER’s NextGen Portal instead! (for submissions not required in eCTD)

This webinar provides an overview of CDER’s NextGen Portal for those in industry who are currently not required to submit in eCTD and are sending information to CDER in paper. CDER’s NextGen Portal is designed to allow a sponsor who normally submits in paper to easily transmit an electronic version instead.


  • Research IND Sponsors planning to submit in paper to CDER
  • Sponsors and Applicant Holders who received an eCTD waiver for their NDA, BLA, ANDA, DMF, or Commercial IND and planning to submit in paper to CDER

After this webinar, participants will be able to:

  • Understand the different submission mechanism (ESG, CDER NextGen Portal, CDER Direct) to submit to CDER
  • Know when to use and when not to use CDER NextGen Portal (i.e., eCTD vs non-eCTD, CDER Submission vs CBER Submission)
  • Register an account on the CDER NextGen Portal
  • Submit electronically instead of paper through CDER’s NextGen Portal

Click here to watch webinar: https://www.fda.gov/drugs/news-events-human-drugs/still-submitting-paper-cder-send-electronically-cders-nextgen-portal-instead-submissions-not?utm_campaign=SBIA%3A%20NextGen%20Webinar&utm_medium=email&utm_source=Eloqua

Categories FDA Regulatory
Tagged , ,

Follow this blog